Biodistribution of Idursulfase Formulated for Intrathecal Use (Idursulfase-IT) in Cynomolgus Monkeys after Intrathecal Lumbar Administration

Enzyme replacement therapy with intravenous idursulfase (recombinant iduronate-2-sulfatase) is approved for the treatment of Hunter syndrome. Intravenous administration does not, however, treat the neurological manifestations, due to its low central nervous system bioavailability. Using intrathecal-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jou-Ku, Brown, Eilish, Crooker, Bob, Palmieri, Kathleen J., McCauley, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072681/
https://www.ncbi.nlm.nih.gov/pubmed/27764180
http://dx.doi.org/10.1371/journal.pone.0164765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072681/
https://www.ncbi.nlm.nih.gov/pubmed/27764180
http://dx.doi.org/10.1371/journal.pone.0164765

Ejemplares similares